http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016148444-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82962e22b6ae66d43ee1e8c950d93db |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 |
filingDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8ff431b4cd5e757700725ec9132a9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989d2017c1963967084597509e5acd04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d45777e87ac84a511b0a6030a7afff2 |
publicationDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2016148444-A1 |
titleOfInvention | Novel desfesoterodine derivative, pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same |
abstract | The present invention relates to a novel desfesoterodine derivative or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a novel desfesoterodine derivative or a pharmaceutically acceptable salt thereof, which is biostable and is effective in the treatment of overactive bladder symptoms such as urinary incontinence, urinary urgency and urinary frequency, and a pharmaceutical composition comprising same for prevention and treatment of overactive bladder symptoms such as urinary incontinence, urinary urgency and urinary frequency. |
priorityDate | 2015-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.